Auranofin Promotes Mitochondrial Apoptosis by Inducing Annexin A5 Expression and Translocation in Human Prostate Cancer Cells

REFERENCES

• Alderden, R. A., Hall, M. D., and Hambley, T. W. 2006. The discovery and development of cisplatin. J. Chem. Edu. 83: 728–734.
   Web of Science ®Google Scholar
• Borg, G., Allander, E., Lund, B., Berg, E., Brodin, U., Petterson, H., and Trang, L. 1988. Auranofin improves outcome in early rheumatoid arthritis. Results from a 2-year, double blind placebo controlled study. J. Rheumatol. 15: 1747–1754.
   PubMed Web of Science ®Google Scholar
• Carvalho Rodrigues, M. A., Gobe, G., Santos, N. A., and Santos, A. C. 2012. Carvedilol protects against apoptotic cell death induced by cisplatin in renal tubular epithelial cells. J. Toxicol. Environ. Health A 75: 981–990.
   PubMed Web of Science ®Google Scholar
• Collier, D. S., Grant, R. W., Estey, G., Surrao, D., Chueh, H. C., and Kay, J. 2009. Physician ability to assess rheumatoid arthritis disease activity using an electronic medical record-based disease activity calculator. Arthritis Rheum. 61: 495–500.
   PubMed Web of Science ®Google Scholar
• Gromer, S., Arscott, L. D., Williams, C. H., Jr., Schirmer, R. H., and Becker, K. 1998. Human placenta thioredoxin reductase. Isolation of the selenoenzyme, steady state kinetics, and inhibition by therapeutic gold compounds. J. Biol. Chem. 273: 20096–20101.
   PubMed Web of Science ®Google Scholar
• Hashimoto, K., Whitehurst, C. E., Matsubara, T., Hirohata, K., and Lipsky, P. E. 1992. Immunomodulatory effects of therapeutic gold compounds. J. Clin. Invest. 89: 1839–1848.
   PubMed Web of Science ®Google Scholar
• Jeong, J. J., Park, N., Kwon, Y. J., Ye, D. J., Moon, A., and Chun, Y. J. 2014. Role of annexin A5 in cisplatin-induced toxicity in renal cells: Molecular mechanism of apoptosis. J. Biol. Chem. 289: 2469–2481.
   PubMed Web of Science ®Google Scholar
• Jiang, N., Kham, S. K., Koh, G. S., Suang Lim, J. Y., Ariffin, H., Chew, F. T., and Yeoh, A. E. 2011. Identification of prognostic protein biomarkers in childhood acute lymphoblastic leukemia (ALL). J. Proteomics 74: 843–857.
   PubMed Web of Science ®Google Scholar
• Keinan, N., Tyomkin, D., and Shoshan-Barmatz, V. 2010. Oligomerization of the mitochondrial protein voltage-dependent anion channel is coupled to the induction of apoptosis. Mol. Cell. Biol. 30: 5698–5709.
   PubMed Web of Science ®Google Scholar
• Kim, S. Y., and Moon, A. 2012. Drug-induced nephrotoxicity and its biomarkers. Biomol. Ther. 20: 268–272.
   PubMed Web of Science ®Google Scholar
• Kheifets, V., Bright, R., Inagaki, K., Schechtman, D., and Mochly-Rosen, D. 2006. Protein kinase Cδ (PKCδ)-annexin V interaction: A required step in PKCδ translocation and function. J. Biol. Chem. 281: 23218–23226.
   PubMed Web of Science ®Google Scholar
• Koopman, G., Reutelingsperger, C. P. M., Kuijten, G. A. M., Keehnen, R. M. J., Pals, S. T., and van Oers, M. H. J. 1994. Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood 84: 1415–1420.
   PubMed Web of Science ®Google Scholar
• Kwon, Y. J., Jung, J. J., Park, N. H., Ye, D. J., Kim, D., Moon, A., and Chun, Y. J. 2013. Annexin a5 as a new potential biomarker for cisplatin-induced toxicity in human kidney epithelial cells. Biomol. Ther. 21: 190–195.
   PubMed Web of Science ®Google Scholar
• Liu, C., Liu, Z., Li, M., Li, X., Wong, Y. S., Ngai, S. M., Zheng, W., Zhang, Y., and Chen, T. 2013. Enhancement of auranofin-induced apoptosis in MCF-7 human breast cells by selenocystine, a synergistic inhibitor of thioredoxin reductase. PLoS One 8: e53945.
   PubMed Web of Science ®Google Scholar
• Majumder, P. K., Pandey, P., Sun, X., Cheng, K., Datta, R., Saxena, S., Kharbanda, S., and Kufe, D. 2000. Mitochondrial translocation of protein kinase Cδ in phorbol ester-induced cytochrome c release and apoptosis. J. Biol. Chem. 275: 21793–21796.
   PubMed Web of Science ®Google Scholar
• Marzano, C., Gandin, V., Folda, A., Scutari, G., Bindoli, A., and Rigobello, M. P. 2007. Inhibition of thioredoxin reductase by auranofin induces apoptosis in cisplatin-resistant human ovarian cancer cells. Free Radical Biol. Med. 42: 872–881.
   PubMed Web of Science ®Google Scholar
• McKeage, M. J., Maharaj, L., and Berners-Price, S. J. 2002. Mechanisms of cytotoxicity and antitumor activity of gold(I) phosphine complexes: The possible role of mitochondria. Coord. Chem. Rev. 232: 127–135.
   Web of Science ®Google Scholar
• Mirabelli, C. K., Johnson, R. K., Hill, D. T., Faucette, L. F., Girard, G. R., Kuo, G. Y., Sung, C. M., and Crooke, S. T. 1986. Correlation of the in vitro cytotoxic and in vivo antitumor activities of gold(I) coordination complexes. J. Med. Chem. 29: 218–223.
   PubMed Web of Science ®Google Scholar
• Park, S. J., and Kim, I. S. 2005. The role of p38 MAPK activation in auranofin-induced apoptosis of human promyelocytic leukaemia HL-60 cells. Br. J. Pharmacol. 146: 506–513.
   PubMed Web of Science ®Google Scholar
• Sanders, M. 2000. A review of controlled clinical trials examining the effects of antimalarial compounds and gold compounds on radiographic progression in rheumatoid arthritis. J. Rheumatol. 27: 523–529.
   PubMed Web of Science ®Google Scholar
• Scharstuhl, A., Mutsaers, H. A., Pennings, S. W., Russel, F. G., and Wagener, F. A. 2009. Involvement of VDAC, Bax and ceramides in the efflux of AIF from mitochondria during curcumin-induced apoptosis. PLoS One 4: e6688.
   PubMed Web of Science ®Google Scholar
• Shaw, I. C. 1999. Gold-based therapeutic agents. Chem. Rev. 99: 2589–2600.
   PubMed Web of Science ®Google Scholar
• Shoshan-Barmatz, V., Keinan, N., Abu-Hamad, S., Tyomkin, D., and Aram, L. 2010. Apoptosis is regulated by the VDAC1 N-terminal region and by VDAC oligomerization: Release of cytochrome c, AIF and Smac/Diablo. Biochim. Biophys. Acta 1797: 1281–1291.
   PubMed Web of Science ®Google Scholar
• Tajeddine, N., Galluzzi, L., Kepp, O., Hangen, E., Morselli, E., Senovilla, L., Araujo, N., Pinna, G., Larochette, N., Zamzami, N., Modjtahedi, N., Harel-Bellan, A., and Kroemer, G. 2008. Hierarchical involvement of Bak, VDAC1 and Bax in cisplatin-induced cell death. Oncogene 10: 4221–4232.
   Web of Science ®Google Scholar
• van Engeland, M., Ramaekers, F. C. S., Schutte, B., and Reutelingsperger, C. P. 1996. A novel assay to measure loss of plasma membrane asymmetry during apoptosis of adherent cells in culture. Cytometry 24: 131–139.
   PubMedGoogle Scholar
• Xiao, T., Choudhary, S., Zhang, W., Ansari, N. H., and Salahudeen, A. 2003. Possible involvement of oxidative stress in cisplatin-induced apoptosis in LLC-PK1 cells. J. Toxicol. Environ. Health A 66: 469–479.
   PubMed Web of Science ®Google Scholar